Dgci
-
Ahmedabad crime branch uncovers major irregularities in clinical drug trials | EXCLUSIVE
Gujarat | Oct 09, 2025, 06:14 PM ISTA comprehensive report has been submitted to the Health Department, Municipal Corporation and the Drugs Controller General of India (DCGI) for further action.
-
DGCI issues notice to Amazon, Flipkart among other e-pharmacies over sale of drugs without license
Business | Feb 12, 2023, 10:42 PM ISTThe notice states that the sale or stock or exhibit or offer for sale or distribution of any drug requires a licence from the concerned state licensing authority and conditions of a licence are required to be complied with by the licence holders.
-
Covid-19: Zydus seeks DCGI nod to undertake clinical trials for monoclonal antibodies cocktail
India | May 27, 2021, 01:41 PM ISTZydus said it is the only Indian company to have developed a neutralizing monoclonal antibody based cocktail for the treatment of COVID-19.
-
DGCI approves Bharat Biotech's Covaxin for phase 2/3 trials on children
India | May 13, 2021, 11:45 AM ISTCovaxin is currently being administered to the people in the country along with Covishield. Hyderabad-based Bharat Biotech is manufacturing Covaxin.
-
India gets third Covid-19 vaccine as DGCI approves Russia's Sputnik V for emergency use
India | Apr 13, 2021, 09:29 AM ISTSputnik V Vaccine Approved in India: DGCI has approved Russia's Sputnik V vaccine for emergency use in India. Sputnik V becomes the third vaccine that will be administered to Indians.
-
Zydus Cadila seeks DCGI nod for use of hepatitis drug for COVID-19 treatment
India | Apr 05, 2021, 02:02 PM ISTDrug firm Zydus Cadila on Monday said it has sought approval from the domestic drug regulator Drugs Controller General of India (DCGI) for the additional indication of its hepatitis drug Pegylated Interferon Alpha-2b for treating COVID-19.
-
DGCI grants approval for clinical trials for third dose of Covaxin
India | Apr 02, 2021, 01:03 PM ISTThe expert panel of India's drug regulator, DCGI, has permitted Bharat Biotech to give the third dose of Covaxin to a few volunteers in its clinical trials of the COVID-19 vaccine.
-
Some Political Parties don't want India to be Aatmnirbhar : Sambit Patra
News | Jan 04, 2021, 05:17 PM ISTBJP National Spokesperson Sambit Patra on monday held a press conference at BJP HQ where he hit back at the Congress over the questions raised by congress party over the DGCI's approval of two indegenous vaccines for usage.
-
Zydus Cadila gets DCGI nod to initiate Phase-3 clinical trials for COVID-19 vaccine
India | Jan 03, 2021, 04:46 PM ISTDrug firm Zydus Cadila on Sunday said it has received DCGI approval to initiate Phase III clinical trials of its COVID-19 vaccine ZyCoV-D.
-
Covid vaccine is here! Serum Institute, Bharat Biotech get approval for restricted use in India
News | Jan 03, 2021, 04:27 PM ISTIn a significant development, Drugs Controller General of India (DGCI) on Sunday (January 3) formally approved Oxford-AstraZeneca's Covishield and Bharat Biotech's Covaxin for use in India.
-
We'll never approve anything if there is slightest of safety concern, vaccines are 100% safe: DCGI
News | Jan 03, 2021, 12:30 PM ISTThe expert panel has recommended granting permission for restricted emergency use of 'Covaxin' in "public interest as an abundant precaution, in clinical trial mode, especially in the context of infection by mutant strains.
-
Healthcare, frontline workers will get vaccines in 1st phase: Satyendra Jain
News | Jan 03, 2021, 12:40 PM ISTDrug Controller General of India (DCGI) on Sunday approved Serum Institute of India's 'Covishield' vaccine and Bharat Biotech's 'Covaxin' for emergency use against coronavirus.
-
Covid vaccine is here! Serum Institute, Bharat Biotech get approval
India | Jan 03, 2021, 11:56 AM ISTIn a significant development, Drugs Controller General of India (DGCI) on Sunday (January 3) formally approved Oxford-AstraZeneca's Covishield and Bharat Biotech's Covaxin for use in India.
-
AIDAN asks DCGI to withdraw approval for Bharat Biotech's Covaxin
India | Jan 03, 2021, 08:01 AM ISTThe AIDAN has said it is shocked to learn about the recommendation to grant REU approval to Bharat Biotech's COVAXIN in "clinical trial mode" and "specially in the context of infection by mutant strains".
-
DGCI detects evasion of GST by 2 liquor manufacturers in Maharashtra
India | Aug 01, 2020, 02:42 PM ISTThe Directorate General of Goods and Services Tax Intelligence (DGGI) has found alleged evasion of GST collectively worth over Rs 108 crore by two liquor manufacturers in Aurangabad and Nanded districts of Maharashtra
-
DCGI sends notice to Glenmark for false claims, overpricing of COVID-19 drug FabiFlu
India | Jul 19, 2020, 10:11 PM ISTThe Drug Controller General of India (DCGI) issued notices to Glenmark seeking clarification from the company regarding the false claim that its antiviral drug Fabiflu, is effective on COVID-19 patients with co-morbidities.
-
Indian scientists devise 16 disaster management drugs
India | Jan 13, 2013, 06:01 PM ISTNew Delhi,Jan 13: Preparing to deal with any future chemical, biological, radiological and nuclear (CBRN) incidents, Indian scientists have devised 16 drugs that can be used for disaster management. These include an anti-cyanide drug, an